Please note: This website has recently moved from www.health.gov to odphp.health.gov. www.health.gov is now the official website of ODPHP’s parent organization, the Office of the Assistant Secretary for Health (OASH). Please update your bookmarks for easy access to all our resources. 

Treating Concurrent Substance Use Among Adults

About this resource:

Non-Systematic Review

Source: Substance Abuse and Mental Health Services Administration

Last Reviewed: September 2021

This Substance Abuse and Mental Health Services Administration (SAMHSA) guide presents 3 evidence-based practices that engage and improve outcomes for people with concurrent substance use and concurrent substance use disorders:

  • FDA-approved pharmacotherapy, together with counseling, to treat alcohol and cocaine dependence or cocaine and opioid dependence
  • Contingency management, together with FDA-approved pharmacotherapy and counseling, to treat cocaine and opioid use and dependence or cocaine dependence and alcohol and opioid use
  • 12-step facilitation therapy, together with FDA-approved pharmacotherapy and counseling, to treat cocaine and opioid dependence or opioid and other substance dependence
Read more about this resource

Objectives related to this resource (1)

Suggested Citation

1.

Substance Abuse and Mental Health Services Administration. (2021). Treating Concurrent Substance Use Among Adults. Retrieved from https://www.samhsa.gov/resource/ebp/treating-concurrent-substance-use-among-adults.